The Alzheimer’s drug pipeline is healthier than you might think

There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 different drugs, of which 12 are set to complete their final “phase 3” trials this year.

Science